Amin Jagani, from Hygeia Group, recently participated in the symposium, “De-Risking Innovation – How Pharma Leaders are Preparing for AI”. This 2nd Annual Sip, Savour, & Innovate Event for Toronto Pharma Visionaries was hosted by ODAIA at their Headquarters in Toronto last week.
The event brought together a dedicated group of pharma leaders and innovators, focusing on exchanging ideas, sharing lessons, and highlighting early successes in AI and innovation within the Pharma & Biotech sectors. An expert panel engaged in discussions surrounding the application of Artificial Intelligence in Pharma, addressing various inquiries from attendees. The panel included:
Key Insights from the Event:
(1) Culture as the Catalyst for Innovation:
Organizations fostering a culture that encourages team experimentation, celebrates small victories, and sets an example for others are best positioned to leverage the potential of AI.
(2) Mitigating Risks in Innovation:
Emphasizing the importance of tackling real business challenges, conducting targeted pilot projects, and ensuring alignment across different functions, rather than just following the latest technological trends.
(3) The Future of Pharma Innovation:
The transformative impact in pharma will stem not from a singular tool but from the seamless integration of AI into everyday operations, fostering smarter and more collaborative teams.
